Hologic, J&J Unit Strike $12.5M Deal In Biopsy IP War

Law360, New York (February 19, 2010, 6:07 PM EST) -- Medical device company Hologic Inc. has agreed to pay $12.5 million to end a long-running patent battle with Johnson & Johnson unit Ethicon Endo-Surgery Inc., putting to rest three lawsuits over biopsy products.

Under the deal, which the companies announced Friday, Hologic will also pay Ethicon ongoing royalties on sales of its Atec and Eviva biopsy products, and Ethicon will pay Hologic ongoing royalties on sales of its Mammotome MR biopsy product.

Neither party has admitted liability, and each will bear its own litigation costs, according...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.